COVID deaths plunge after major world city introduced ivermectin

Authorities create home-treatment-kit for 22 million-strong population.

A citywide initiative in Mexico City to prescribe ivermectin to COVID-19 patients resulted in a plunge in hospitalizations and deaths, two studies found.

Hospitalizations were down by as much as 76%, according to research by the Mexican Digital Agency for Public Innovation, Mexico’s Ministry of Health and the Mexican Social Security Institute, according to a TrialSiteNews report highlighted by LifeSiteNews.

Earlier this month, as WND reported, a significant decrease in cases in India coincided with the national health ministry’s promotion of ivermectin and hydroxychloroquine treatments.

In Mexico City, after a spike in cases in December, the city’s Ministry of Health created a home-treatment kit for residents. The city’s metro population is 22 million.

At the time, the head of the Mexico City Ministry of Health, Oliva López, said told reporters her agency had determined “that there is enough evidence to use in people positive for SARS-CoV-2, even without symptoms, some drugs such as ivermectin and azithromycin.”

Beginning Dec. 29, people who tested positive for COVID from an antigen test and who were experiencing at least mild symptoms began receiving one of the government’s ivermectin-based treatment kits, TrialSiteNews reported.

The Mexican government then began a study to track the impact of the early treatment of COVID with ivermectin on the city’s population.

The study tracked 200,000 people, dividing in two cohorts — those who received ivermectin and those who did not.

Through a phone-call-based monitoring system and hospital data on admissions for COVID-19, the researchers found a reduction of between 52% and 76% in hospitalizations for those who took ivermectin compared to those who did not.

The government’s findings were corroborated by Dr. Juan J. Chamie-Quintero, a senior data analyst at private Colombian university EAFIT.

He found that excess deaths in the city dropped sharply only a few weeks after the ivermectin treatments began.

Chamie-Quintero also conducted a study in Peru, where the government approved ivermectin as a treatment for the virus in May 2020.

In the 24 Peruvian states that adopted early use of ivermectin treatment, excess deaths plummeted on average by 59% just 30 days after the peak death rate. And it had dropped 75% after 45 days in those over 60 years old.

‘Large, statistically significant reductions in mortality’

Worldwide, more than 50 peer-reviewed studies have shown the effectiveness of ivermectin as a treatment and prophylaxis against COVID-19.

A study by the American Journal of Therapeutics that analyzed 18 randomized controlled treatment trials found ivermectin elicited “large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance” in COVID patients.

The study concluded that “the many examples of ivermectin distribution campaigns leading to rapid population-wide decreases in morbidity and mortality indicate that an oral agent effective in all phases of COVID-19 has been identified.”

In February, a peer-reviewed study found that invermectin reduces coronavirus infections, hospitalizations and deaths by about 75%.

Ivermectin, in more than 30 trials around the world, causes “repeated, consistent, large magnitude improvements in clinical outcomes’ at all stages of the disease,” according to the study, which was published in the U.S. journal Frontiers of Pharmacology.

The evidence is so strong, the researchers believe, the anti-parasitic drug should become a standard therapy everywhere, hastening global recovery.

“The data is overwhelming – we are in a pandemic, and this is an incredibly effective way to combat it. If we use ivermectin widely, our societies can open up,” said study co-author Professor Paul Marik, director of emergency and pulmonary care at Eastern Virginia Medical School.

A previous study by Professor Andrew Hill of Liverpool University also found ivermectin cuts death rates by about 75%.

LATEST VIDEO